Nutrien Ltd.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, -10.8% a year, held within -10% to 25% (statements).
US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt less cash at the end of FY2025 (statements); negative means more cash than debt.
What today's price assumes
A market value of $33.0 B means free cash flow growing 7.9% a year for 10 years, then 2.5% for ever, at a 10.15% discount rate.
Revenue grew -10.8% a year over the last three years.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | -15% | -12.5% | -10% | -7.5% | -5% |
|---|---|---|---|---|---|
| 8.15% | -95% | -89% | -81% | -72% | -61% |
| 9.15% | -98% | -93% | -86% | -79% | -70% |
| 10.15% | -100% | -96% | -90% | -84% | -76% |
| 11.15% | -102% | -98% | -93% | -88% | -81% |
| 12.15% | -103% | -100% | -96% | -91% | -85% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Nutrien Ltd., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Agriculture Related
Multiples of its companies with a market value at most 60 days old, times Nutrien Ltd.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Nutrien Ltd. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 7.5× / 14.3× / 22.6× | 14.6× | net income $2.3 B | $16.9 B to $51.1 B | 20 |
| Price to sales | 0.5× / 1.6× / 2.6× | 1.2× | revenue $26.9 B | $14.0 B to $71.0 B | 26 |
| Price to book | 0.5× / 1.8× / 4.6× | 1.3× | book equity $25.3 B | $12.7 B to $116.0 B | 20 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Nutrien Ltd.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
P/E
14.6×Now close to its median of 14.4×; range 3.7× to 86.0× over 9 months.
Price to sales
1.2×Now close to its median of 1.3×; range 0.7× to 1.9× over 9 months.
Price to book
1.3×Now close to its median of 1.3×; range 1.1× to 1.8× over 9 months.
as of Oct 31, 2026. Market caps: the dated values on file since 2020. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 31, 2026.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $26.9 B | $2.3 B | $4.0 B | $1.9 B | $2.1 B | $8.6 B | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | $26.0 B | $674 M | $3.5 B | $2.0 B | $1.5 B | $8.0 B | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $29.1 B | $1.3 B | $5.1 B | $2.4 B | $2.7 B | $8.0 B | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $37.9 B | $7.7 B | $8.1 B | $2.3 B | $5.9 B | $7.1 B | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $27.7 B | $3.2 B | $3.9 B | $1.8 B | $2.1 B | $7.0 B | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $20.9 B | $459 M | $3.3 B | $1.4 B | $1.9 B | $8.6 B | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $33.0 B on Oct 31, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.